Shares of vaccine makers slumped in premarket trading, extending losses for a second day after President-elect Donald Trump nominated Robert F. Kennedy Jr. as the Secretary of Health and Human Services. Wall Street analysts told clients this development has sparked vast uncertainty across the biotechnology sector. 

The 70-year-old Kennedy has been a longtime health advocate, and Trump said he would let Kennedy “go wild” should he win the November 5 election.

Trump said during his victory speech.

However, making America healthy again will require a complete overhaul of the FDA and USDA. Kennedy could dismantle the longstanding cozy relationships between big pharma and the federal government during Trump’s second term. This very prospect spooked vaccine stocks in premarket trading in New York, extending losses from Thursday.

US Premarket: 

EU Cash: 

“Healthcare/Pharma in focus this morning (GSXEPHAR), following Robert F Kennedy being confirmed as Trump’s nominee for health secretary which sparked a pharma and specifically vaccine makers sell off into the close yesterday. To this point, Kennedy has been vocal on vaccines in the past, seen as one of the most prominent anti-vaxxer’s in the US. Hence witnessing a -3sd move in our Pharma basket,” Goldman’s Martin Ehigiator told clients on Friday morning.

Deutsche Bank analyst Emmanuel Papadakis told clients this morning that his team slashed GSK’s rating to “Hold” following the news. 

Kennedy’s track record of questioning experimental mRNA vaccines and taking on government bureaucracies overseeing the vaccine industry has caught the attention of many Americans… 

He stated earlier this year:

And, of course, Kennedy taking on big pharma’s corruption in federal agencies and the entire public health sector is just bad news for profits. Wall Street analysts outlined this very clearly to clients (courtesy of Bloomberg): 

RBC Capital Markets

JPMorgan

Wells Fargo

TD Cowen

RBC’s Abrahams noted, “Whether RFK ultimately takes the seat is still uncertain,” adding, “The Senate may push back.” 

Kennedy founded the nonprofit Children’s Health Defense about a decade ago, one of the most well-funded organizations focusing on children’s health. 

Meanwhile, CNN’s Sanjay Gupta melted down over Kennedy’s new possible role to head up HHS. 

Gupta said.

CNN freaking out about @RobertKennedyJr taking over HHS: “Somebody said to me today, ‘I can’t think of any single individual who would be more damaging to public health than RFK'” pic.twitter.com/r4742BvIwF

— Tom Elliott (@tomselliott) November 14, 2024

In other words, Kennedy would disrupt and ban big vaccine companies from controlling the airwaves with advertising dollars, and in return, ad revenues for CNN and other MSM outlets would plummet. 

Also, Stephen Colbert threw a tantrum overnight because this meant the late-night show’s ad revenues from big pharma would implode.

CNN freaking out about @RobertKennedyJr taking over HHS: “Somebody said to me today, ‘I can’t think of any single individual who would be more damaging to public health than RFK'” pic.twitter.com/r4742BvIwF

— Tom Elliott (@tomselliott) November 14, 2024

Colbert was big pharma’s cheerleader. 

Stephen Colbert, winning hearts and minds of the vaccine hesitant pic.twitter.com/fa98vRrcRj

— Daily Caller (@DailyCaller) September 29, 2021

Before the 2020 election Stephen Colbert was doing skits encouraging people to be skeptical of Big Pharma and its motives. After the election he was dancing like a fool while surrounded by people dressed as syringes. pic.twitter.com/9IXtxKRi7M

— MAZE (@mazemoore) March 29, 2024

Why does the only remedy for illness always seem to be vaccines and medicines from big pharma? Well, it’s a big business. Eating healthy and exercising doesn’t make Wall Street money. It’s time for reform.